Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
about
Anthrax lethal and edema toxins in anthrax pathogenesisCellular and physiological effects of anthrax exotoxin and its relevance to disease.Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticlesDetection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescenceKinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaquesBiochip for the Detection of Bacillus anthracis Lethal Factor and Therapeutic Agents against Anthrax Toxins.In trans complementation of lethal factor reveal roles in colonization and dissemination in a murine mouse model.Circulating lethal toxin decreases the ability of neutrophils to respond to Bacillus anthracis.Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake.Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma.Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex.Mouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin.Combination of two candidate subunit vaccine antigens elicits protective immunity to ricin and anthrax toxin in miceTranscriptome analysis identifies Bacillus anthracis genes that respond to CO2 through an AtxA-dependent mechanism.Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasuresMechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.Anthrax edema toxin impairs clearance in mice.Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculatureDomain specificity of the human antibody response to Bacillus anthracis protective antigen.In vitro evaluation, biodistribution and scintigraphic imaging in mice of radiolabeled anthrax toxinsMatrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis.Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbedIdentification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies.Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.Membrane translocation by anthrax toxin.Anthrax toxin protective antigen--insights into molecular switching from prepore to poreThe potential of toxin-based drug delivery systems for enhanced nucleic acid therapeutic delivery.Human serum contains a protease that protects against cytotoxic activity of Bacillus anthracis lethal toxin in vitro.Genome engineering in Bacillus anthracis using tyrosine site-specific recombinases.Defensive strategies of Bacillus anthracis that promote a fatal disease.Serum-Mediated Cleavage of Bacillus anthracis Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase.
P2860
Q26852034-B3788180-B350-4964-8EB0-D2C4F09EEF6FQ27010363-75645F0B-A9F6-47A6-B1D7-D61A26217424Q28387667-2E5D66E4-CE51-4105-8A1D-715F11DDA346Q28388732-2086F43C-C4F0-40CF-AA5A-2AE7172D46FDQ28389893-589D67F2-8C56-4EFB-8C24-D7FE943B8948Q30389824-B6390988-25B9-4076-9C85-953FED56838DQ30413638-D0E58219-839E-4FAE-9F36-CC8BCA595F24Q30457081-619BD400-9E82-4313-937A-8F3F9C119EFDQ33667710-C2691F6A-BDDB-433B-81CB-210FDEAB81DAQ33942561-D0204F95-EC8D-4EF5-891D-552975501562Q34069693-B26AF9E3-7182-4D73-B6EA-55DAA962866DQ34134769-9303BE36-1972-4564-82E1-E3D0A33FAEA5Q34759081-AED011FB-31BA-40EA-84EA-789B98F82622Q35128886-1AF855D7-F825-42C0-88B8-329DAE6C7584Q35155807-70AA18D0-6930-4A85-9872-3A99FE871552Q35173029-2F243D54-7013-486C-9FFF-48BBFCFE8B85Q35205013-968997F8-9E6A-43DD-845B-67966AE5C7DBQ35459294-9F091C9E-C0B3-42D5-8E1E-2AB039C3A141Q35689507-D1531D86-61B7-4D6C-B56F-079248235D6BQ35887551-D61B745F-A59B-4060-A68A-809CDE82D033Q36671847-7C7F5323-A0A3-403D-9F84-81033F3E5479Q36876723-42E5A7A1-456E-468F-B31A-3A373AC24162Q37037248-100BDDAF-BC1D-4EB1-9933-CE6DE1B3FE3EQ37178467-55BCF2AC-2F8E-42DA-9B8F-1777D66B1B04Q37191250-A8AF1F75-21F5-4BAA-B30E-3165AEA8B9DDQ37375729-B4C2D609-654B-4072-885A-1D32CAB08B4DQ37404847-4BCF840E-3350-4F1D-BAF0-FA8D8F8E5A43Q37535082-F7A50849-2006-46B6-A566-16C2B2788B34Q37957788-1DA35355-4227-4E07-8C91-CAB7B35DC197Q38934039-8F18668D-1091-46BC-AE8C-D317C4395F6BQ39755368-7665259D-FE85-4C81-B724-FC7DAA876154Q40084328-C63C9C07-3BB3-4E12-AA96-8309D9C43822Q41114190-C02A6A02-08ED-452A-A6EA-86389AB4E5C0Q55379780-02C6D7EB-784D-4729-9930-7939CC347A6C
P2860
Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
@ast
Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
@en
type
label
Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
@ast
Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
@en
prefLabel
Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
@ast
Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
@en
P2860
P356
P1476
Anthrax protective antigen cleavage and clearance from the blood of mice and rats.
@en
P2093
Jason F Wiggins
P2860
P304
P356
10.1128/IAI.00719-07
P407
P577
2007-08-27T00:00:00Z